Nucleoside Phosphoramidate Prodrugs

Patent No. EP2203462 (titled "Nucleoside Phosphoramidate Prodrugs") was filed by Gilead Pharmasset on Mar 26, 2008. The application was issued on Sep 25, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (10)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2203462

GILEAD PHARMASSET
Application Number
EP08732818A
Filing Date
Mar 26, 2008
Status
Patent Maintained As Amended
Aug 22, 2024
Publication Date
Sep 25, 2024